Posted inBiotechnology
Hemodynamic Effects of High-Flow vs. CPAP in Preterm Neonates
In a groundbreaking study recently published in Pediatric Research, scientists have unveiled compelling insights into the hemodynamic effects of two…
Posted inBiotechnology
Dynamic Cross-Strand Interactions Boost DNA Language Models
In a groundbreaking development at the intersection of genomics and artificial intelligence, a team of scientists has unveiled a novel…
Posted inBiotechnology
Ammonia Hydrates Shape Enceladus’s South Polar Ice
The icy moon Enceladus, one of Saturn’s most intriguing celestial bodies, has long captivated scientists with its dynamic geophysical activity…
Posted inBiotechnology
Widespread Trypsin–MBL Module Blocks Phages
In an era where bacterial defenses against viral invaders are critically important, a groundbreaking study published in Nature Chemical Biology…
Posted inBiotechnology
RUNX1-Driven GCN5 Boosts ICOSLG, Activates T Cells
A groundbreaking study published in Experimental & Molecular Medicine has unveiled a critical molecular mechanism that drives T cell activation…
Posted inBiotechnology
Physics-Trained Digital ‘Super-Brain’ Accelerates Technology Innovation
A groundbreaking advance in the integration of foundational physics with artificial intelligence heralds a new era in the development of…
Posted inBiotechnology
Innovative Gold-Palladium Catalysis Mechanism Poised to Transform Bio-Based Chemical Manufacturing
In the contemporary quest to replace petrochemical-derived materials with renewable bio-based alternatives, the chemical industry stands on the cusp of…
Posted inBiotechnology
Autobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2
A stimulator of thyroid hormone receptors in the brain has successfully reduced depression severity in patients with bipolar disorder, positioning…
Posted inBiotechnology
As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
Two federal lawmakers have introduced a bill seeking to apply the review requirements of the Comprehensive Outbound Investment National Security…
Posted inBiotechnology
Parabilis preps $413M IPO to fuel desmoid tumor drug into phase 3
Parabilis Medicines is gearing up for an IPO that could eventually bring in as much as $476 million to fund…